Neuvotion Expands Partnership with Intelligent Product Solutions and Commercializes NeuStim™ Technology for Stroke and Spinal Cord Injury

Rhea-AI Summary

Neuvotion, an early-stage medical device company, has expanded its partnership with Intelligent Product Solutions (IPS) to commercialize its NeuStim™ technology for stroke and spinal cord injury treatment. Forward Industries, IPS's parent company, has made an undisclosed investment in Neuvotion to accelerate the market launch of NeuStim™.

The company specializes in AI-driven neuromodulation technologies for neurorehabilitation, brain-computer interface, and physical therapy markets. The partnership leverages IPS's medical device design and engineering expertise to bring Neuvotion's solutions to market, aiming to improve patient recovery outcomes.

Positive

• Strategic partnership secured with established engineering firm IPS
• Received new investment from Forward Industries
• Advancing towards market launch of first product NeuStim™

Negative

• Investment amount remains undisclosed
• Product still in pre-market phase
• Early-stage company with no current market presence

 STAMFORD, Conn., Dec. 17, 2024 /PRNewswire/ -- Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products for use in the neurorehabilitation, brain-computer interface (BCI), and physical therapy markets. Today Neuvotion has announced their expanded partnership with Intelligent Product Solutions (IPS), a leading engineering firm located in New York.  Forward Industries, the parent company of IPS, has made an undisclosed investment deal with Neuvotion, Inc. to further propel the company towards market launch of its first product, NeuStim™.

Neuvotion expands partnerships to launch groundbreaking products in neuromodulation and neurorehabilitation markets.

"Neuvotion's mission is to develop and bring innovative technologies to the medical market that significantly improve patient outcomes, independence, and overall quality of life," said Chad Bouton, Neuvotion's founder and CEO. "We are extremely excited about the growth of Neuvotion and our expanded partnership with IPS."

"We are proud to help Neuvotion innovate in the rapidly growing neuromodulation and neurorehabilitation markets," said Bob Wild, COO of Intelligent Product Solutions. "NeuStim™ is truly groundbreaking and has the potential to significantly improve recovery outcomes for patients recovering from stroke or spinal cord injury. IPS, with our multidisciplinary team of designers, engineers, and scientists is thrilled to provide medical device design and engineering expertise as Neuvotion brings their life-changing solutions to market."

About Neuvotion, Inc.
Neuvotion is an early-stage medical device company developing solutions for facilitating and restoring movement and sensation to the millions of patients experiencing impairment from stroke, spinal cord injury, and other conditions. Neuvotion's technologies combine high-precision neurostimulation and artificial intelligence to accelerate rehabilitation while making physical and occupational therapy more effective and efficient.

About Intelligent Product Solutions 
Intelligent Product Solutions (IPS), a subsidiary of Forward Industries (NASDAQ: FORD), is an award-winning global product design and development company with headquarters in New York. IPS specializes in every stage of product development, from research and discovery to manufacturing, with expertise in systems architecture, industrial and UI/UX design, mechanical engineering, software development, electrical engineering, embedded systems, and manufacturing. To learn more about IPS, visit https://intelligentproduct.solutions or contact info@ips-yes.com.

If you would like more information about this topic, please email info@neuvotion-inc.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/neuvotion-expands-partnership-with-intelligent-product-solutions-and-commercializes-neustim-technology-for-stroke-and-spinal-cord-injury-302332352.html

SOURCE Neuvotion, Inc.

FAQ

What is the purpose of Forward Industries' investment in Neuvotion (FORD)?

Forward Industries' investment in Neuvotion aims to accelerate the market launch of NeuStim™, their neuromodulation technology for stroke and spinal cord injury treatment.

What markets will Neuvotion's NeuStim™ technology target?

NeuStim™ technology targets the neurorehabilitation, brain-computer interface (BCI), and physical therapy markets, specifically focusing on stroke and spinal cord injury treatment.

How will the IPS partnership benefit Neuvotion's product development?

The partnership provides Neuvotion with IPS's medical device design and engineering expertise, supporting the development and commercialization of their NeuStim™ technology.

What is the current development stage of Neuvotion's NeuStim™ technology?

NeuStim™ is in the pre-market phase, with the company working towards its market launch through the expanded partnership with IPS and investment from Forward Industries (FORD).